11.90
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$12.17
Aprire:
$12.19
Volume 24 ore:
1.71M
Relative Volume:
0.39
Capitalizzazione di mercato:
$2.38B
Reddito:
$3.68B
Utile/perdita netta:
$-598.00M
Rapporto P/E:
-3.9698
EPS:
-2.9976
Flusso di cassa netto:
$104.00M
1 W Prestazione:
-1.57%
1M Prestazione:
+3.12%
6M Prestazione:
-9.57%
1 anno Prestazione:
-10.39%
Dentsply Sirona Inc Stock (XRAY) Company Profile
Nome
Dentsply Sirona Inc
Settore
Industria
Telefono
844-546-3722
Indirizzo
13320 BALLANTYNE CORPORATE PLACE, CHARLOTTE, NC
Compare XRAY vs ISRG, BDX, MDLN, ALC, RMD
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
|
XRAY
Dentsply Sirona Inc
|
11.90 | 2.46B | 3.68B | -598.00M | 104.00M | -2.9976 |
|
ISRG
Intuitive Surgical Inc
|
478.82 | 160.28B | 10.58B | 3.00B | 2.83B | 8.2437 |
|
BDX
Becton Dickinson Co
|
154.85 | 44.57B | 21.92B | 1.76B | 2.63B | 6.1223 |
|
MDLN
Medline Inc
|
46.23 | 38.56B | 28.43B | 1.16B | 1.26B | 1.4457 |
|
ALC
Alcon Inc
|
75.86 | 37.93B | 10.40B | 980.00M | 1.61B | 1.9749 |
|
RMD
Resmed Inc
|
219.51 | 32.23B | 5.40B | 1.49B | 1.78B | 10.12 |
Dentsply Sirona Inc Stock (XRAY) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-04-15 | Iniziato | Citigroup | Sell |
| 2026-02-19 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2025-12-09 | Iniziato | Barclays | Underweight |
| 2025-11-07 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2025-04-15 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2025-03-13 | Downgrade | Needham | Buy → Hold |
| 2025-02-14 | Iniziato | Wells Fargo | Equal Weight |
| 2025-01-23 | Downgrade | Jefferies | Buy → Hold |
| 2025-01-07 | Downgrade | Evercore ISI | Outperform → In-line |
| 2024-12-04 | Iniziato | Mizuho | Neutral |
| 2024-11-07 | Downgrade | Leerink Partners | Outperform → Market Perform |
| 2024-10-25 | Reiterato | Needham | Buy |
| 2024-08-20 | Reiterato | Needham | Buy |
| 2024-02-26 | Iniziato | Leerink Partners | Outperform |
| 2023-11-16 | Iniziato | Needham | Buy |
| 2023-11-10 | Aggiornamento | William Blair | Mkt Perform → Outperform |
| 2023-01-12 | Aggiornamento | William Blair | Underperform → Mkt Perform |
| 2022-08-05 | Downgrade | William Blair | Mkt Perform → Underperform |
| 2022-06-02 | Aggiornamento | UBS | Neutral → Buy |
| 2022-04-20 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2022-04-20 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2022-04-19 | Downgrade | BofA Securities | Buy → Neutral |
| 2022-04-19 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2022-01-31 | Iniziato | Morgan Stanley | Overweight |
| 2021-10-01 | Ripresa | Credit Suisse | Outperform |
| 2021-08-09 | Reiterato | H.C. Wainwright | Neutral |
| 2021-08-06 | Reiterato | Barrington Research | Outperform |
| 2021-08-05 | Ripresa | Credit Suisse | Outperform |
| 2021-03-02 | Aggiornamento | Barrington Research | Mkt Perform → Outperform |
| 2021-03-02 | Reiterato | H.C. Wainwright | Neutral |
| 2021-01-05 | Reiterato | H.C. Wainwright | Neutral |
| 2020-12-18 | Downgrade | Stifel | Buy → Hold |
| 2020-11-17 | Downgrade | Barclays | Equal Weight → Underweight |
| 2020-11-09 | Reiterato | H.C. Wainwright | Neutral |
| 2020-10-22 | Aggiornamento | Guggenheim | Neutral → Buy |
| 2020-08-10 | Reiterato | H.C. Wainwright | Neutral |
| 2020-06-16 | Iniziato | Piper Sandler | Overweight |
| 2020-06-15 | Reiterato | H.C. Wainwright | Neutral |
| 2020-05-27 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2020-05-11 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| 2020-04-24 | Reiterato | H.C. Wainwright | Neutral |
| 2020-04-08 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2020-04-07 | Downgrade | Goldman | Buy → Neutral |
| 2020-04-02 | Aggiornamento | Wolfe Research | Peer Perform → Outperform |
| 2020-03-03 | Reiterato | H.C. Wainwright | Neutral |
| 2020-02-19 | Reiterato | Stifel | Buy |
| 2019-12-11 | Downgrade | JP Morgan | Overweight → Neutral |
| 2019-08-02 | Aggiornamento | Wellington Shields | Hold → Gradually Accumulate |
| 2019-07-26 | Iniziato | Evercore ISI | In-line |
| 2019-07-09 | Reiterato | H.C. Wainwright | Neutral |
| 2019-05-30 | Iniziato | Wolfe Research | Peer Perform |
Mostra tutto
Dentsply Sirona Inc Borsa (XRAY) Ultime notizie
DENTSPLY SIRONA : 2025 Annual Report - marketscreener.com
[ARS] DENTSPLY SIRONA Inc. SEC Filing - Stock Titan
15M-share incentive plan boost on Dentsply Sirona (NASDAQ: XRAY) 2026 ballot - Stock Titan
Dental Hand Instrument Market Is Booming So Rapidly | Dentsply Sirona, Henry Schein Inc, HuFriedy Mfg. Co LLC, 3M - openPR.com
Dentsply Sirona to Host First Quarter 2026 Conference Call on May 5 - Yahoo Finance
Dentsply Sirona Inc stock (US24906P1093): Why does its dental tech leadership matter more now for st - AD HOC NEWS
Dentsply Sirona Inc stock (US24906P1093): Is its dental equipment dominance still the key to steady - AD HOC NEWS
Reasons to retain DENTSPLY SIRONA stock in your portfolio now - MSN
Evaluating Dentsply Sirona (XRAY) After Recent Share Price Rebound And Deep Discount To Estimated Fair Value - Sahm
XRAY & Siemens Healthineers secure FDA nod for dental-dedicated MRI - MSN
Bruker, Amneal, Amphastar Pharmaceuticals, Dentsply Sirona, and PacBio Stocks Trade Up, What You Need To Know - Yahoo Finance
DENTSPLY SIRONA (NASDAQ:XRAY) Rating Increased to Strong Sell at Citigroup - MarketBeat
Dentsply Sirona Inc stock (US9839191015): Is its consumables dominance strong enough to unlock new u - AD HOC NEWS
Conical Dental Implant Market 2026-2033: Growth Overview, - openPR.com
Citi Maintains Dentsply Sirona(XRAY.US) With Sell Rating, Maintains Target Price $10 - Moomoo
Great Hill Capital LLC Boosts Stake in DENTSPLY SIRONA - National Today
DENTSPLY SIRONA (XRAY) Stock: Price vs Value (In Focus) 2026-04-16Price Target - Xã Thanh Hà
Great Hill Capital LLC Takes $8.27 Million Position in DENTSPLY SIRONA Inc. $XRAY - MarketBeat
Citigroup initiates coverage of DENTSPLY SIRONA (XRAY) with sell recommendation - MSN
XRAY Initiated Coverage by Citigroup -- Rating Set to Sell - GuruFocus
XRAY Director Acquires 2,638 Phantom Stock Shares April 15, 2026 - Meyka
Dentsply Sirona Inc stock (US24906P1093): Why does its dental consumables dominance matter more now? - AD HOC NEWS
Dentsply Sirona’s Implant Solutions World Summit 2026 unveils scientific programme and masterclasses - Dental Tribune US
$13+ Bn Dental Laboratories MarketGlobal Forecast to - GlobeNewswire
Dentsply Sirona Inc stock (US24906P1093): Is consumables strength enough to drive steady U.S. invest - AD HOC NEWS
Is DENTSPLY SIRONA (XRAY) Stock Consolidating | Price at $11.79, Down 0.59%Viral Momentum Stocks - Cổng thông tin điện tử Tỉnh Sơn La
SG Americas Securities LLC Invests in DENTSPLY SIRONA - National Today
SG Americas Securities LLC Makes New Investment in DENTSPLY SIRONA Inc. $XRAY - MarketBeat
DENTSPLY SIRONA: Another Episode Of An Anticipated Recovery (NASDAQ:XRAY) - Seeking Alpha
Handpieces Market Size Surging at 6.5% CAGR | Major Players: Kavo, NSK, Dentsply Sirona, W&H, Bien Air - openPR.com
Evercore Maintains Dentsply Sirona(XRAY.US) With Hold Rating, Cuts Target Price to $13 - Moomoo
Analyst Calls: What is the dividend yield of DENTSPLY SIRONA IncEntry Point & Short-Term Trading Alerts - baoquankhu1.vn
Growth Report: Is DENTSPLY SIRONA Inc in a long term uptrend2026 Big Picture & Daily Entry Point Trade Alerts - baoquankhu1.vn
DENTSPLY SIRONA Inc. $XRAY Shares Sold by Wealth Enhancement Advisory Services LLC - MarketBeat
Sound Income Strategies LLC Raises Holdings in DENTSPLY SIRONA Inc. $XRAY - MarketBeat
Dentsply Sirona webinar to spotlight ortho-restorative workflow - Dental Tribune US
DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Given Average Recommendation of "Hold" by Analysts - MarketBeat
UBS Maintains DENTSPLY SIRONA (XRAY) Buy Recommendation - MSN
DENTSPLY SIRONA Inc. (DY2.F) Analyst insights, Price targets and Recommendations - Yahoo Finance Singapore
Director at Dentsply Sirona (XRAY) receives deferred phantom stock award - Stock Titan
Dental Implants and Prosthetics Market is expected to Hit US$ - openPR.com
Dental Syringe Market Is Going to Boom Rapidly With Top Key Players BD • Henry Schein • Dentsply Sirona • Hu-Friedy - openPR.com
JPMorgan Chase & Co. Has $5.29 Million Stock Position in DENTSPLY SIRONA Inc. $XRAY - MarketBeat
Factors Supporting the Continued Inclusion of DENTSPLY SIRONA Shares in Your Investment Portfolio - Bitget
Reasons to Retain DENTSPLY SIRONA Stock in Your Portfolio Now - TradingView
XRAY Should I Buy - Intellectia AI
A Look At Dentsply Sirona (XRAY) Valuation After Soft Growth And Diminishing Returns Concerns - Sahm
Buybacks Report: Is DENTSPLY SIRONA Inc exposed to political riskTrade Performance Summary & Daily Profit Focused Stock Screening - baoquankhu1.vn
Dentsply Sirona integrates VDW brand into unified identity - Dental Tribune US
Aug Action: Is DENTSPLY SIRONA Inc stock good for income investors2026 EndofMonth & Smart Investment Allocation Tips - baoquankhu1.vn
3 Reasons to Avoid XRAY and 1 Stock to Buy Instead - Yahoo Finance
Dentsply Sirona Inc Azioni (XRAY) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):